The Cell and gene therapy market growth in 2026 represents a revolutionary approach in modern medicine, focusing on modifying or replacing defective genes and cells to treat diseases at their root cause. These therapies are gaining momentum due to their potential to provide long-term or even permanent treatment outcomes, particularly in oncology, rare genetic disorders, and autoimmune diseases. The increasing number of clinical trials and regulatory approvals is further accelerating market growth globally.
According to Fortune Business Insights, the global Cell and Gene Therapy Market size was valued at USD 12.21 billion in 2025 and is projected to grow from USD 16.45 billion in 2026 to USD 143.55 billion by 2034, exhibiting a CAGR of 31.10% during the forecast period. The rapid expansion of this market reflects the increasing adoption of advanced therapies designed to treat, prevent, and potentially cure complex genetic and chronic diseases. North America dominated the cell and gene therapy market with a market share of 52.58% in 2025, driven by strong research infrastructure, favorable regulatory frameworks, and high investments in biotechnology innovation.
The growing prevalence of chronic and genetic diseases is one of the primary drivers of the cell and gene therapy market. The rising demand for personalized medicine and targeted therapies has significantly boosted research and development activities in this field. Additionally, advancements in gene-editing technologies, such as CRISPR, and increasing investments from both public and private sectors are fueling innovation.
Another major growth factor is the increasing number of successful clinical trials and product approvals, which are encouraging healthcare providers to adopt these therapies. Furthermore, strong support from regulatory authorities for accelerated approval pathways has enhanced market penetration.
However, the market faces certain restraints, including the high cost of therapy development and treatment, which limits accessibility for many patients. Manufacturing complexities, stringent regulatory requirements, and challenges in large-scale production also act as barriers to growth. Despite these challenges, continuous technological advancements are expected to mitigate these issues over time.
The cell and gene therapy market report provides comprehensive insights into market size, share, growth trends, and future forecasts. It covers detailed analysis of key market segments, competitive landscape, and regional performance. The report highlights emerging opportunities, technological advancements, and strategic initiatives adopted by leading players. It also includes in-depth information about clinical developments, regulatory scenarios, and investment trends shaping the market.